Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Vitamin D protects skin cells from damage caused by captopril.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Certain drugs that block specific enzymes can help treat prostate diseases.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Axitinib treatment turned a man's grey hair back to black.

Finasteride improves heart function and repairs damage after heart attack in mice.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Ritlecitinib is safe and may effectively treat alopecia areata.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.